The effect of ALG on coagulation and fibrinolysis

Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2000

NovoSeven as a universal haemostatic agent.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2000

Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies.

Vox sanguinis·1999

Acute renal impairment due to a primary aortocaval fistula is normalised after a successful operation.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·1999

The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1999

The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1998

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Thrombosis research·2026

Plasma kallikrein in breast cancer cells: Interactions with urokinase plasminogen activator system and syndecans.

Thrombosis research·2026

Risk of cancer after incident venous thromboembolism or cerebral venous thrombosis: Evidence from an Italian administrative healthcare database cohort (2002-2023).

Thrombosis research·2026

Subclinical carotid atherosclerosis in patients with retinal vein occlusion: Differential cardiovascular risk profiles.

Thrombosis research·2026

Clinical and molecular characteristics of hereditary factor XII deficiency in Chinese Han patients: Novel mutations, a high-frequency frameshift variant, and plasma metabolomic profiling.

Thrombosis research·2026

Distinct coagulation-fibrinolysis profiles in traumatic and upper gastrointestinal hemorrhagic shock: Clinical relevance of tPA/PAI-1 complex in traumatic hemorrhagic shock.

Thrombosis research·2026

Endobronchial lipoma presenting as a fat-attenuation lesion causing left upper lobar bronchial obstruction: A case report.

Radiology case reports·2026

Immunomodulation of microglia/macrophages and neutrophils as immunotherapeutic targets in ischemic stroke: A narrative review.

Brain circulation·2026

Kidney Allograft Outcomes in Borderline and T Cell-Mediated Rejection With Microvascular Inflammation.

Kidney international reports·2026

Overlap Myositis in a Patient With Psoriasis Treated With Anti-TNF-Alpha Therapy: A Case Report and Review of Literature.

Case reports in rheumatology·2026

Case Report: From idiopathic recurrent pericarditis to systemic Behçet's Disease: unmasking a unified IL-1-driven autoinflammatory phenotype.

Frontiers in immunology·2026

Lower invasiveness of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: evidence from AJCC 8th-edition stratification and a dose-response relationship with autoantibody titers.

Frontiers in endocrinology·2026

Related Experiment Videos

The effect of ALG on coagulation and fibrinolysis

Related Concept Videos

Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk.

NovoSeven as a universal haemostatic agent.

Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies.

Acute renal impairment due to a primary aortocaval fistula is normalised after a successful operation.

The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0.

The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Plasma kallikrein in breast cancer cells: Interactions with urokinase plasminogen activator system and syndecans.

Risk of cancer after incident venous thromboembolism or cerebral venous thrombosis: Evidence from an Italian administrative healthcare database cohort (2002-2023).

Subclinical carotid atherosclerosis in patients with retinal vein occlusion: Differential cardiovascular risk profiles.

Clinical and molecular characteristics of hereditary factor XII deficiency in Chinese Han patients: Novel mutations, a high-frequency frameshift variant, and plasma metabolomic profiling.

Distinct coagulation-fibrinolysis profiles in traumatic and upper gastrointestinal hemorrhagic shock: Clinical relevance of tPA/PAI-1 complex in traumatic hemorrhagic shock.

Endobronchial lipoma presenting as a fat-attenuation lesion causing left upper lobar bronchial obstruction: A case report.

Immunomodulation of microglia/macrophages and neutrophils as immunotherapeutic targets in ischemic stroke: A narrative review.

Kidney Allograft Outcomes in Borderline and T Cell-Mediated Rejection With Microvascular Inflammation.

Overlap Myositis in a Patient With Psoriasis Treated With Anti-TNF-Alpha Therapy: A Case Report and Review of Literature.

Case Report: From idiopathic recurrent pericarditis to systemic Behçet's Disease: unmasking a unified IL-1-driven autoinflammatory phenotype.

Lower invasiveness of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: evidence from AJCC 8th-edition stratification and a dose-response relationship with autoantibody titers.

Related Experiment Videos

The effect of ALG on coagulation and fibrinolysis

Related Concept Videos

Related Articles